United States Electromyogram Monitoring Market Report 2019: Overview, Analysis And Forecast, Drivers And Limiters & Competitive Market Share Analysis

News provided by

Apr 08, 2019, 05:00 ET

DUBLIN, April 8, 2019 /PRNewswire/ -- The "Electromyogram Monitoring Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

New electrodiagnostic EMG device purchases will be modest, driven primarily by replacement sales, and alternate care sites are expected to show little demand moving forward. However, sales of consumables are expected to continue to rise and cause the market to grow towards the end of the forecast period. Competitive price cutting by vendors will continue to temper growth potential within the market, offset in part by the established installed base and increasing procedural volumes.

Electromyography (EMG) devices measure the electrical activity in muscles and the functionality of the nervous system to find the cause of muscle malfunctions. Disorders causing nerve impairment can affect muscle function, due to improper firing of electrical pulses. Some examples of nervous system complications include amyotrophic lateral sclerosis (ALS), carpal tunnel syndrome and myasthenia gravis (MG). EMG monitoring and diagnostic capabilities are limited to nerve and muscle function and are not able to diagnose brain or spinal cord diseases.

Key Topics Covered:

1. Executive Summary
U.S. Patient Monitoring Equipment Market Overview
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology

2. Electromyogram Monitoring Market
2.1 Introduction
2.1.1 Neuropathy
2.1.2 Myopathy
2.1.3 Applications
2.1.4 Complications
2.2 Market Overview
2.3 Market Analysis And Forecast
2.3.1 Total EMG Monitor Market
2.3.1.1 Hospital EMG Monitor Market
2.3.1.2 Alternate Care EMG Monitor Market
2.3.2 Total EMG Consumables Market
2.3.2.1 EMG Concentric Needle Market
2.3.2.2 EMG Monopolar Needle Market
2.3.2.3 EMG Surface Electrode Market
2.4 Drivers And Limiters
2.5 Competitive Market Share Analysis

3. Abbreviations

4. Appendix: Company Press Releases
4.1 Introduction
4.2 Press Releases
4.2.1 Draeger Medical
4.2.1.1 First half of 2018: Drger increases net sales
4.2.1.2 New HealthTrust Agreement Covers Drger's Line of Anesthesia Solutions
4.2.1.3 Drger and ICON Prepared to Support Hospitals with Ventilators During Times of Crisis
4.2.1.4 Drger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.5 Drger Infinity M300 Monitor Now Features FIPS Security
4.2.1.6 Drger First to Achieve DIACAP Certification for Patient Monitoring and Clinical IT Systems
4.2.1.7 Drger to Discuss Alarm Management and Strategies for Eliminating Alarm Fatigue at HIMSS16
4.2.2 Edwards Lifesciences
4.2.2.1 Edwards Lifesciences Reports Second Quarter Results
4.2.2.2 Edwards' Acumen Hypotension Prediction Index Launches In The U.S.
4.2.2.3 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.4 Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
4.2.2.5 Edwards Acquires Harpoon Medical
4.2.2.6 Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
4.2.2.7 Edwards Lifesciences Reports Fourth Quarter Results
4.2.2.8 Edwards Lifesciences Completes Acquisition Of Valtech Cardio
4.2.2.9 Edwards Receives CE Mark For Hypotension Probability Indicator
4.2.2.10 Edwards Lifesciences Reports Second Quarter Results
4.2.2.11 Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors
4.2.2.12 Edwards Lifesciences Reports First Quarter Results
4.2.2.13 Steven Loranger Appointed To Edwards Lifesciences Board Of Directors
4.2.2.14 Edwards Lifesciences Reports Fourth Quarter Results
4.2.3 Fukuda Denshi
4.2.3.1 Fukuda Denshi Introduces the UF-760AG Color Portable Ultrasound System in the U.S. A High Performance Color Portable Ultrasound Unit Designed for a Wide Array of Specialty Markets
4.2.3.2 Hospitals, Healthcare Providers to Save with the Fukuda Denshi USA Inc. and Amerinet Choice License and Supply Agreement
4.2.4 GE Healthcare
4.2.4.1 GE Healthcare Introduces Virtual Reality Training for Healthcare Technology Management Professionals
4.2.4.2 GE Healthcare and FitTrace announce collaboration to offer body composition analysis software for sports and fitness markets
4.2.4.3 GE Healthcare and Preventice Solutions Collaborate to Extend the Heart Station Beyond the Hospital
4.2.4.4 Veritas Capital to Acquire Revenue-Cycle, Ambulatory Care and Workforce Management Software Unit from GE Healthcare for $1 Billion
4.2.4.5 GE Healthcare, Ferozsons L.L. and P&SHD collaborate to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH)
4.2.4.6 Ministry of Health and GE delivering digital solutions to bring transformative change to Kingdom's healthcare sector
4.2.4.7 GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
4.2.4.8 Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years

Companies Mentioned

Natus Medical
Nihon Kohden
Cadwell Laboratories
Ambu
Neuroelectrics
Shimmer and Spes Medica

For more information about this report visit https://www.researchandmarkets.com/research/nmlp9k/united_states?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets